Management of Hypotensive Cirrhotic Patient with E. coli Bacteremia

Initial Resuscitation and Hemodynamic Management

The American Association for the Study of Liver Diseases recommends immediate treatment with balanced crystalloids and/or albumin for fluid resuscitation, with norepinephrine as the first-line vasopressor targeting a mean arterial pressure of 65 mmHg, along with broad-spectrum antibiotics for hypotensive cirrhotic patients with E. coli bacteremia 1, 2, 3
Early baseline assessment of volume status, perfusion, and cardiovascular function should be performed, ideally with bedside echocardiography to evaluate cardiac function and guide management 1, 3
Judicious intravascular volume resuscitation using balanced crystalloids and/or albumin should be implemented, while avoiding normal saline and monitoring for fluid overload 1, 2, 3
A mean arterial pressure of 65 mmHg should be targeted with ongoing assessment of end-organ perfusion; invasive hemodynamic monitoring may be needed for adequate assessment 1, 4
Norepinephrine should be used as the first-line vasopressor with concurrent appropriate fluid resuscitation 1, 2
Vasopressin should be added as a second-line agent when increasing doses of norepinephrine are required 1, 4
Screening for adrenal insufficiency or an empiric trial of hydrocortisone should be considered for refractory shock requiring high-dose vasopressors 1, 4

Broad-spectrum antibiotics should be started immediately upon suspicion of infection, and aminoglycosides should be avoided due to increased risk of nephrotoxicity in cirrhotic patients 5, 6

Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided due to risk of acute kidney injury, hyponatremia, and diuretic resistance 5, 6
Angiotensin-converting enzyme inhibitors, angiotensin II antagonists, and α1-adrenergic blockers should be avoided due to risk of worsening hypotension and renal impairment 5, 6
Diagnostic paracentesis should be considered to rule out spontaneous bacterial peritonitis as a source of infection in patients with ascites 6
Albumin should be administered (8 g/L of ascites removed) to prevent circulatory dysfunction if large-volume paracentesis is required 5, 6

Patients should be closely monitored for signs of clinical improvement or deterioration, including vital signs, urine output, mental status, and laboratory parameters 1
Volume status and hemodynamic parameters should be reassessed frequently to guide ongoing fluid and vasopressor therapy 1, 3